2025年96%普通股基上涨 融通产业趋势股票涨114%

Group 1 - In 2025, 930 out of 969 comparable ordinary equity funds achieved positive performance, representing 96% of the total, while only 39 funds experienced declines [1] - The top-performing fund, Rongtong Industry Trend Stock, achieved a remarkable return of 114.61%, managed by Li Jin, who has been with Rongtong since 2017 and became a fund manager in 2023 [1] - The fund's top ten holdings in Q3 2025 included stocks from sectors such as optical modules, high-end manufacturing, and biomedicine, with a notable concentration in semiconductor-related stocks in the second half of the year [1] Group 2 - E Fund's Strategic Emerging Industry Stock A and C funds recorded returns of 107.60% and 106.74%, respectively, with top holdings including stocks from Tencent, Alibaba, and Zhongji Xuchuang [2] - The E Fund's Information Industry Selected Stock A and C funds also performed well, with returns of 104.31% and 103.26%, benefiting from the semiconductor sector [2] - Other funds that doubled their performance included Red Soil Innovation New Technology Stock A and Caitong Integrated Circuit Industry Stock A, with returns of 104.91% and 101.46% [2] Group 3 - A total of 14 ordinary equity funds saw returns exceeding 90%, including Huashang High-end Equipment Manufacturing Stock A and Longxin Innovation Driven Stock [3] - Conversely, the biomedicine and consumer sectors lagged significantly, leading to declines of 17.81% and 17.29% for Shenwan Lixin Medical Pioneer Stock A and C [3] - The top holdings of the underperforming funds included various biopharmaceutical companies, indicating a sector-specific weakness [3][4] Group 4 - The underperforming funds, such as Taikang Medical Health Stock A and C, were heavily invested in pharmaceutical stocks, which contributed to their declines of 13.45% and 13.02% [4] - Longxin Consumer Selected Quantitative Stock A and C also faced declines of 12.76% and 12.41%, with a focus on liquor stocks in their top holdings [4]